— Guide
Lyophilization and compound stability
How freeze-drying turns a fragile peptide solution into a multi-year shelf-stable powder, and why every Merit lot ships lyophilized.
Every Merit research compound ships as a lyophilized (freeze-dried) powder rather than a ready-to-use liquid. There's a reason — and it's worth understanding because the stability characteristics of the lyophilized vs. reconstituted forms are dramatically different.
What lyophilization actually does
Lyophilization is the process of freezing a compound solution and then removing the water by sublimation under vacuum — meaning the ice transitions directly from solid to vapor without passing through a liquid phase. The result is a dry, structurally stable powder (sometimes called a "lyophilized cake") that contains the compound minus essentially all of the water.
The process happens in three stages:
- Freezing. The compound solution is cooled rapidly to well below its freezing point (typically -40 °C or colder). Slow freezing produces large ice crystals that can damage compound structure; rapid freezing produces small crystals that don't.
- Primary drying. The frozen material is held under high vacuum at moderate temperatures (-20 to 0 °C). Ice sublimates from the frozen mass, leaving the compound behind in a porous structure that maintains the original volume.
- Secondary drying. Temperature is raised further (often to 20–30 °C) under continued vacuum to remove residual bound water. The end result has typically <3% residual moisture.
Why this matters for stability
Compounds degrade primarily through water-mediated reactions: hydrolysis of the compound bonds, deamidation of asparagine and glutamine residues, oxidation, and aggregation. Remove the water and most of these reactions slow by orders of magnitude. A compound that is stable for 30 days reconstituted at 2–8 °C is typically stable for 24+ months lyophilized at -20 °C.
The other major benefit is mechanical: lyophilized powders are tolerant of transit temperature variation in ways solutions are not. A reconstituted vial that warms to room temperature for a few hours during shipping has been compromised. A lyophilized vial that does the same is fine — the dry powder doesn't degrade meaningfully at room temperature on short timescales.
The trade-off
Lyophilization isn't free. The compound arrives in solid form and the researcher has to reconstitute it before use — adding a step, requiring sterile technique, and introducing a window where dosing errors can happen. This is the trade Merit (and essentially every research compound supplier) makes: extra step at the researcher's end in exchange for dramatically longer shelf life and cold-chain tolerance.
For research models that require ready-to-use solutions, the alternative is to receive the lyophilized form and reconstitute it once, then aliquot for the duration of the study. The 30-day reconstituted shelf life is usually adequate for an experimental cohort.
What a good lyophilized cake looks like
| Appearance | Interpretation |
|---|---|
| Solid, intact white or off-white cake | Normal — full structural integrity preserved |
| Cake with small fissures | Acceptable — fissures from freeze-cycle volume changes don't affect stability |
| Cake collapsed against vial wall | Cosmetic only — compound is still stable; reconstitution unaffected |
| Cake melted into a film on vial bottom | Compromised — the vial may have been exposed to temperatures above the glass transition temperature during storage. Do not use; contact Merit. |
| Yellow or brown discoloration | Compromised — oxidation or thermal damage. Do not use. |
Excipients in the lyophilized form
Most research compounds are lyophilized with a small amount of bulking agent (typically mannitol or trehalose) and sometimes a stabilizer (sucrose or amino acids). These serve two purposes:
- They form the structural matrix of the lyophilized cake, preventing it from collapsing during drying.
- They protect the compound from freezing damage during the initial cooling step.
For most research applications, excipient quantities are too small to interfere with experimental measurements. The COA documents the excipient composition. Where it matters (mass spec quantification, certain in-vitro assays), the excipient composition can be accounted for in calculations.
Reconstitution returns the compound to liquid form
Adding bacteriostatic water (or sterile water) to the lyophilized cake rehydrates the compound back into solution. The compound reforms its native conformation if the original lyophilization preserved the structure — which is the entire engineering challenge of pharmaceutical-grade lyophilization. Visible cake → clear solution within ~30–60 seconds for well-lyophilized material.
Why Merit ships every compound lyophilized
Even compounds that could theoretically be shipped as solutions (small, stable compounds with good aqueous solubility) get lyophilized at Merit. The reason is consistency: a single shipping format, a single set of cold-chain expectations, a single stability protocol. The 30-second reconstitution step at the lab end is a small ask in exchange for not having to worry about temperature excursions during transit.
For research use only. Storage conditions described above reflect compound-handling literature; verify against the COA's stated stability data for each specific compound.
For research use only. Not for human or veterinary use. Not FDA-approved. Reference information summarized from published literature — not medical or dosing advice.
— More handling & testing
Aliquoting a compound vial safely
How to split a reconstituted peptide vial into single-use aliquots so you avoid freeze-thaw degradation and contamination.
Bacteriostatic water vs. sterile water: which to use
The practical difference between bacteriostatic water (USP, with benzyl alcohol) and sterile water for injection, and why bacteriostatic is the default for multi-dose peptide vials
Choosing the right syringe and needle for research workflows
How to pick between insulin syringes, 1 mL tuberculin syringes, and various needle gauges based on dose volume and reconstitution practice.
Cold-chain handling: from delivery to vial
What to do when a peptide shipment arrives — verifying ice-pack temperature, transferring vials to long-term storage, and what counts as a stability-compromising thermal excursion.